We are live on ! Find out more
MRCM

M&R Capital Management Portfolio holdings

AUM $454M
1-Year Est. Return 40.11%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$419M
AUM Growth
+$10.9M
Cap. Flow
+$2.31M
Cap. Flow %
0.55%
Top 10 Hldgs %
47.82%
Holding
559
New
11
Increased
126
Reduced
102
Closed
12

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$8.37M
2
CACI icon
CACI
CACI
+$5.74M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$2.32M
4
PEP icon
PepsiCo
PEP
+$1.38M
5
ACGL icon
Arch Capital
ACGL
+$1.25M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$8.98M
2
CMCSA icon
Comcast
CMCSA
+$2.47M
3
LW icon
Lamb Weston
LW
+$2.32M
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$1.3M
5
MMM icon
3M
MMM
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 27.36%
2 Financials 20.03%
3 Healthcare 10.65%
4 Communication Services 9.1%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NWN icon
351
Northwest Natural Holdings
NWN
$2.08B
$11.8K ﹤0.01%
328
+10
+3% +$370
VLO icon
352
Valero Energy
VLO
$101B
$11.8K ﹤0.01%
75
-2
-3% -$323
NXN
353
DELISTED
Nuveen New York Tax-Free Income Portfolio
NXN
$11.7K ﹤0.01%
1,000
– –
UGI icon
354
UGI
UGI
$8.15B
$11.4K ﹤0.01%
496
+7
+1% +$170
BIPC icon
355
Brookfield Infrastructure
BIPC
$4.75B
$11.3K ﹤0.01%
336
-50
-13% -$1.67K
PJP icon
356
Invesco Pharmaceuticals ETF
PJP
$522M
$11.1K ﹤0.01%
135
– –
ROL icon
357
Rollins
ROL
$17.5B
$11K ﹤0.01%
225
– –
PBA icon
358
Pembina Pipeline
PBA
$27.9B
$10.9K ﹤0.01%
295
– –
IQI icon
359
Invesco Quality Municipal Securities
IQI
$538M
$10.9K ﹤0.01%
1,100
– –
SCHF icon
360
Schwab International Equity ETF
SCHF
$69.3B
$10.7K ﹤0.01%
558
– –
TMP icon
361
Tompkins Financial
TMP
$1.41B
$10.7K ﹤0.01%
219
+3
+1% +$138
SPYV icon
362
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
$10.7K ﹤0.01%
219
+113
+107% +$5.52K
GUT
363
Gabelli Utility Trust
GUT
$573M
$10.6K ﹤0.01%
1,831
-8
-0.4% -$45
SCHD icon
364
Schwab US Dividend Equity ETF
SCHD
$111B
$10.5K ﹤0.01%
405
– –
FBTC icon
365
Fidelity Wise Origin Bitcoin Fund
FBTC
$14.4B
$10.5K ﹤0.01%
+200
New +$11.5K
PGR icon
366
Progressive
PGR
$127B
$10.4K ﹤0.01%
50
– –
GLW icon
367
Corning
GLW
$128B
$10.3K ﹤0.01%
265
– –
BLMN icon
368
Bloomin' Brands
BLMN
$906M
$10.1K ﹤0.01%
528
+42
+9% +$985
XRAY icon
369
Dentsply Sirona
XRAY
$2.22B
$10.1K ﹤0.01%
405
+1
+0.2% +$29
KMB icon
370
Kimberly-Clark
KMB
$36.4B
$10.1K ﹤0.01%
73
-34
-32% -$4.54K
WPC icon
371
W.P. Carey
WPC
$16.1B
$10K ﹤0.01%
182
+3
+2% +$169
BBJP icon
372
JPMorgan BetaBuilders Japan ETF
BBJP
$19.1B
$9.82K ﹤0.01%
174
– –
IJS icon
373
iShares S&P Small-Cap 600 Value ETF
IJS
$8.28B
$9.73K ﹤0.01%
100
– –
BBY icon
374
Best Buy
BBY
$17.4B
$9.67K ﹤0.01%
115
+2
+2% +$159
VNM icon
375
VanEck Vietnam ETF
VNM
$525M
$9.62K ﹤0.01%
790
– –
13 14
15
16 17

Similar funds

EDRIA
Edmonds Duncan Registered Investment Advisors Lawrence, Kansas $457M AUM 23% 1-Year Est. Return
SFP
Sweet Financial Partners Fairmont, Minnesota $462M AUM 26.73% 1-Year Est. Return
AC
Albar Capital London, United Kingdom $445M AUM 55.79% 1-Year Est. Return
NIC
Northwest Investment Counselors Lake Oswego, Oregon $442M AUM 29.9% 1-Year Est. Return
WCA
Waypoint Capital Advisors Minneapolis, Minnesota $470M AUM 32.8% 1-Year Est. Return
KC
Kingfisher Capital Charlotte, North Carolina $437M AUM 41.72% 1-Year Est. Return
SIGI
Susquehanna International Group (Ireland) Dublin, Ireland $472M AUM 25.62% 1-Year Est. Return
FPFS
First Personal Financial Services Charlotte, North Carolina $473M AUM 28.33% 1-Year Est. Return

M&R Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, M&R Capital Management held 559 positions worth $419M, up 2.7% from $408M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 4.1%. M&R Capital Management opened 11 new positions and exited 12, leaving the 559-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • M&R Capital Management's largest Q2 2024 buy was KeyCorp: 11,973 shares worth $170K.
  • M&R Capital Management added most to AstraZeneca in Q2 2024, an estimated $8.37M increase.
  • M&R Capital Management's biggest Q2 2024 reduction was CVS Health, cutting an estimated $8.98M.
  • M&R Capital Management fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $42.7K.
  • M&R Capital Management's ten largest holdings make up 48% of its $419M portfolio in Q2 2024.
  • M&R Capital Management opened 11 new positions and closed 12 in Q2 2024.
  • M&R Capital Management's portfolio value rose 2.7% quarter-over-quarter to $419M.

Based on M&R Capital Management's 13F filing for Q2 2024, filed 2 Jul 2024.